These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23126361)

  • 1. Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.
    Tadin T; Krpina K; Stifter S; Babarović E; Fučkar Z; Jonjić N
    Diagn Pathol; 2012 Nov; 7():152. PubMed ID: 23126361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes.
    Krpina K; Babarović E; Dorđević G; Fuckar Z; Jonjić N
    Croat Med J; 2012 Dec; 53(6):598-604. PubMed ID: 23275325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma.
    Krpina K; Babarović E; Jonjić N
    Virchows Arch; 2015 Oct; 467(4):443-8. PubMed ID: 26215559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of uroplakin III expression in recurrence of solitary muscle non-invasive bladder cancer.
    Tadin T; Krpina K; Štifter S; Babarović E; Jonjić N
    Pathol Res Pract; 2014 May; 210(5):279-84. PubMed ID: 24553301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer.
    Kim SI; Kwon SM; Kim YS; Hong SJ
    Urology; 2002 Nov; 60(5):816-21. PubMed ID: 12429306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cyclooxygenase-2 immunoreactivity with tumor recurrence and disease progression in superficial urothelial bladder cancer.
    Mokos I; Jakić-Razumović J; Mareković Z; Pasini J
    Tumori; 2006; 92(2):124-9. PubMed ID: 16724691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
    Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
    Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of different p16 immunostaining methods and the prognostic role of p16/Ki-67 combined expression in non-muscle invasive bladder cancers.
    Özyalvaçli G; Özyalvaçli ME; Astarci HM; Boran Ç; Yeşil C; Üyetürk U; Aktaș G
    Pol J Pathol; 2015 Mar; 66(1):57-66. PubMed ID: 26017881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.
    Passoni N; Gayed B; Kapur P; Sagalowsky AI; Shariat SF; Lotan Y
    Urol Oncol; 2016 Nov; 34(11):485.e7-485.e14. PubMed ID: 27637323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.
    Gou Y; Ding W; Xu K; Wang H; Chen Z; Tan J; Xia G; Ding Q
    Int Urol Nephrol; 2015 Feb; 47(2):289-93. PubMed ID: 25388353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
    Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
    Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer.
    Tsai YS; Jou YC; Tung CL; Lin CT; Shen CH; Chen SY; Tsai HT; Lai CL; Wu CL; Tzai TS
    Virchows Arch; 2014 Jun; 464(6):717-24. PubMed ID: 24733561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
    Kramer MW; Golshani R; Merseburger AS; Knapp J; Garcia A; Hennenlotter J; Duncan RC; Soloway MS; Jorda M; Kuczyk MA; Stenzl A; Lokeshwar VB
    Eur Urol; 2010 Jan; 57(1):86-93. PubMed ID: 19345473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
    Ayari C; LaRue H; Hovington H; Caron A; Bergeron A; Têtu B; Fradet V; Fradet Y
    Hum Pathol; 2013 Aug; 44(8):1630-7. PubMed ID: 23574787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer.
    Kohjimoto Y; Iba A; Shintani Y; Inagaki T; Uekado Y; Hara I
    World J Urol; 2010 Aug; 28(4):425-30. PubMed ID: 20130884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Suppressor in Lung Cancer-1 Is a Prognostic Predictor for the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Chen Y; Yang Y; Liu L; Wang S; Song H; Liu X
    Urol Int; 2016; 96(2):142-7. PubMed ID: 26894268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.